Skip to content

Evaluation of the Effectiveness of Day Hospital Care for Adolescents With Anxious School Refusal

Evaluation of the Effectiveness of Day Hospital Care for Adolescents With Anxious School Refusal

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07020013
Acronym
REPECH
Enrollment
80
Registered
2025-06-13
Start date
2025-09-01
Completion date
2026-06-30
Last updated
2025-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

School Phobia

Keywords

School phobia, Anxious school refusal

Brief summary

The objective of the study is to evaluate the benefit of day care in a child psychiatric hospital on the return to school and on the development of child psychiatric disorders associated with Anxious Social Refusal.

Detailed description

This is a prospective, longitudinal, single-center observational cohort study carried out on a population of patients followed in a day hospital for anxious school refusal. Participating physicians will have the opportunity to recruit their patients over a 12-month period. All enrolled patients will be followed for a minimum of 10 months. The study will be completed as soon as the last enrolled patient has completed a final assessment. Aside from the baseline visit, each patient will be assessed only once at 10 months. During each patient visit with the investigating physician, the physician will complete an assessment on the electronic CRF.

Interventions

None listed

Sponsors

GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
12 Years to 18 Years

Inclusion criteria

* Patients aged 12 to 18 years * Patients with anxious school refusal, defined by a score ≥ 41 on the SCREEN scale * Patients receiving day hospital care * Patients who have been informed and whose parents (or holder(s) of parental authority) have agreed to their participation in the study and have not objected to the use of their health data

Exclusion criteria

* Patients with a mental disability or any other reason that may hinder the understanding or strict application of the protocol * Patients not affiliated with the French social security system * Patients under guardianship

Design outcomes

Primary

MeasureTime frameDescription
Anxious school refusalMonth 10The primary endpoint is based on the change in the SCREEN scale score between inclusion and the end of the study. A 20% improvement in this score will be considered as evidence of a benefit from day hospital care on anxious school refusal.

Secondary

MeasureTime frameDescription
Anxiety disorder assessmentMonth 10The Spence Children's Anxiety Scale (SCAS) is a 44-item self-report questionnaire. Each item is rated on a 4-point Likert scale, from 0 (never) to 3 (always). No time period is specified for the scope of the questions. Six of the 44 items are positive items intended to limit the tendency to respond negatively; they are not included in the overall score. The overall score, obtained by adding all 38 items, ranges from 0 to 144. The questionnaire identifies six dimensions of anxiety: Panic Attack and Agoraphobia, Separation Anxiety, Fear of Physical Injury, Social Phobia, OCD, and Generalized Anxiety Disorder.
depressive disorder assessmentMonth 10The Children's Depression Rating Scale - Revised (CDRS) is a revised version of a questionnaire originally derived from the Hamilton Rating Scale for Depression. The total score is an index of the intensity of depressive symptomatology in children aged 6 to 12 years. It is a 17-item, self-assessment tool, completed by a clinician based on a non-directive interview with the child, and supplemented or corrected, based on clinical judgment, with additional information from the family or teachers.
Obsessive-compulsive disorder assessmentMonth 10The Yale-Brown Obsession-Compulsion Scale (CY-BOCS) is a structured interview that provides an assessment of the severity of obsessive-compulsive symptoms unbiased by the presence or absence of a particular type of obsession or compulsion.
Attention Deficit Hyperactivity disorder assessmentMonth 10The ADHD Rating Scale is a specific assessment tool for ADHD. Consisting of the 18 clinical symptoms involved in diagnosing the disorder in the DSM-IV, it quantifies the severity of the disorder and assesses the various dimensions of the disorder (hyperactivity, inattention, and impulsivity). In most clinical studies, a score of 28 or higher is required to qualify ADHD as significant.
Schooling methodMonth 10Current schooling method (or planned in the short term) at month 10
Post traumatic Stress disorder assessmentMonth 10The UCLA Child/Adolescent Posttraumatic Stress Disorder Reaction Index was designed for use with school-aged children and adolescents. The DSM-5 version is a semi-structured interview with a clinician that assesses a child's trauma history and the full range of DSM-5 symptoms and diagnostic criteria for posttraumatic stress disorder. This measure consists of several parts: an assessment of different types of trauma, a DSM-5 posttraumatic stress disorder symptom scale including dissociative symptoms, and an assessment of distress and impairment.

Countries

France

Contacts

Primary Contactsolal STORA, MD
solal.stora@gmail.com04 28 63 16 01

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026